Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
IMMUCELL CORP /DE/
Report date February 11, 2022 · Filed May 18, 2022
Section 16 reporting ended · disclosed 2022-05-18. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2022 Filed Mar 14, 2022 20:00 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, par value $0.10 per share | 1,000 | $5.84 | $5,840.00 |
DisclosureSEC source: 0001213900-22-012143 · doc4.xml · nonDerivative · entry 1 CRABB JOSEPH H · CIK 0001136546 · Former VP and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,845 Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 21:11 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Exercise / conversionIncentive Stock Options · Derivative | Not disclosed | $1.70 Strike: $1.70 | $47,500.00 |
DisclosureSEC source: 0001213900-18-016587 · doc4.xml · derivative · entry 3 CRABB JOSEPH H · CIK 0001136546 · Vice President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1.7 Underlying: Common Stock · 47,500 shares Expires 2019-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 21:11 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Exercise / conversionCommon Stock, par value $0.10 per share | 47,500 | $1.70 | $80,750.00 |
DisclosureSEC source: 0001213900-18-016587 · doc4.xml · nonDerivative · entry 2 CRABB JOSEPH H · CIK 0001136546 · Vice President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,845 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 27, 2018 21:11 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | Disposition to issuerCommon Stock, par value $0.10 per share | 10,766 | $7.50 | $80,745.00 |
DisclosureSEC source: 0001213900-18-016587 · doc4.xml · nonDerivative · entry 1 CRABB JOSEPH H · CIK 0001136546 · Vice President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,345 Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 17:29 UTC | IMMUCELL CORP /DE/ ICCC · Entity 6837 | GrantIncentive Stock Options · Derivative | 1,000 | $5.84 Strike: $5.84 | $5,840.00 |
DisclosureSEC source: 0001547522-17-000017 · doc4.xml · derivative · entry 1 CRABB JOSEPH H · CIK 0001136546 · Director · Vice President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2027-02-09 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.